These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 19020757

  • 1. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
    Brun JL, Cortez A, Commo F, Uzan S, Rouzier R, Daraï E.
    Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M, Ishikura H, Kawarada Y, Ogawa Y, Sakuragi N, Fujimoto S, Yoshiki T.
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
    Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC.
    Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
    [Abstract] [Full Text] [Related]

  • 5. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
    Brun JL, Cortez A, Lesieur B, Uzan S, Rouzier R, Daraï E.
    Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
    [Abstract] [Full Text] [Related]

  • 6. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.
    Kim TJ, Rho SB, Choi YL, Choi CH, Lee JW, Bae DS, Ahn G, Lee JH, Kim BG.
    Hum Pathol; 2006 Jul; 37(7):906-13. PubMed ID: 16784992
    [Abstract] [Full Text] [Related]

  • 7. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors].
    Cai W, Song JD.
    Ai Zheng; 2002 Jan; 21(1):91-4. PubMed ID: 12500407
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC, Lequerica-Fernández P, Santamaría J, Fresno MF.
    J Oral Pathol Med; 2007 Aug 15; 36(7):415-24. PubMed ID: 17617835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.
    J Orofac Pain; 2000 Aug 15; 14(1):20-30. PubMed ID: 11203734
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA, Segura AM, Horiba K, Qian S, Yu ZX, Stetler-Stevenson W, Willerson JT, McAllister HA, Ferrans VJ.
    Hum Pathol; 2002 Dec 15; 33(12):1158-64. PubMed ID: 12514782
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW.
    Lab Invest; 1996 Feb 15; 74(2):406-21. PubMed ID: 8780160
    [Abstract] [Full Text] [Related]

  • 20. Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
    Furuya M.
    Hokkaido Igaku Zasshi; 1999 Mar 15; 74(2):145-55. PubMed ID: 10386163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.